Background
==========

Human ferritin (HFn) is a promising nanoscale protein cage platform for molecular/cellular imaging, and we have developed engineered HFn nanoparticles as MRI agents. Inflammation and angiogenesis contribute to atherosclerosis, and RGD is a well-studied ligand of the α~v~β~3~ integrin expressed by activated macrophages and angiogenic endothelial cells.

Purpose
=======

To evaluate RGD-conjugated HFn-iron oxide nanoparticles for enhanced *in vivo* MRI detection of murine carotid atherosclerosis.

Methods
=======

1) Mice
-------

Fourteen FVB mice underwent left carotid ligation after 4 weeks of high-fat diet and diabetes induction by streptozotocin.

2) RGD-conjugated HFn-iron oxide nanoparticles
----------------------------------------------

Using the recombinant human heavy-chain ferritin protein cage, HFn was genetically engineered to display 24 copies of an RGD-4C peptide (CDCRGDCFC) on the exterior surface of the protein cage. Magnetite (Fe~3~O~4~) was encapsulated in interior cavities of RGD-conjugated HFn (RGD^+^ HFn) and non-targeted HFn (RGD^-^ HFn) at loading factors of 5000Fe per cage, giving R2 values of 93 mM^-1^s^-1^ (magnetite diameter: 5-7nm, exterior diameter: 12nm). The injected dose was adjusted to 25mgFe/kg.

3) MRI
------

Two weeks post ligation, mice were imaged on a whole-body 3T MRI scanner (Signa HDx, GE Healthcare) with a phased array mouse coil (RAPID MR International), using a gradient echo sequence (TR/TE=100ms/10ms, slice thickness=1.0mm, FOV=3cm, matrix=256x256, FA=60, NEX=10). Mice were then injected with either RGD^+^ (n=7) or RGD^-^ (n=7) HFn nanoparticles, followed by MRI at 24 and 48 hours post injection. The nanoparticle accumulation was assessed by measuring the extent of T2\*-induced reduction in carotid lumen size (% reduction of carotid lumen area).

4) Histology
------------

Perl's iron staining was performed to identify accumulation of the nanoparticles in the carotid lesions.

Results
=======

Both RGD^+^ and RGD^-^ HFn nanoparticles caused a reduction in lumen size of the ligated left carotid arteries at 48 hrs due to T2\* signal loss (p\<0.001 vs. preinjection, Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}), but the effect was significantly greater with RGD^+^ HFn (p=0.01 vs. RGD^-^ HFn). There was no significant lumen reduction in the non-ligated (control) right carotid arteries. Perl's iron staining confirmed greater accumulation of RGD^+^ HFn in the lesion compared to RGD^-^ HFn, primarily in neointimal macrophages (Figure [3](#F3){ref-type="fig"}).
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Conclusions
===========

Human ferritin protein cage is a versatile nanoparticle imaging platform for *in vivo* cellular/molecular MRI, with enhanced atherosclerosis imaging through multivalent RGD targeting.
